vs
Esperion Therapeutics, Inc.（ESPR）与null（GPRO）财务数据对比。点击上方公司名可切换其他公司
null的季度营收约是Esperion Therapeutics, Inc.的1.2倍（$201.7M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 0.4%），过去两年null的营收复合增速更高（13.9% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
GoPro, Inc.是2002年由尼克·伍德曼创立的美国科技企业，最初注册名为伍德曼实验室，总部坐落于加利福尼亚州圣马特奥。该公司主营运动相机生产制造，同时还自主开发配套移动端应用与视频编辑软件。
ESPR vs GPRO — 直观对比
营收规模更大
GPRO
是对方的1.2倍
$168.4M
营收增速更快
ESPR
高出143.3%
0.4%
两年增速更快
GPRO
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $201.7M |
| 净利润 | — | — |
| 毛利率 | — | 31.8% |
| 营业利润率 | 50.6% | -4.1% |
| 净利率 | — | — |
| 营收同比 | 143.7% | 0.4% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRGPRO
| Q4 25 | $168.4M | $201.7M | ||
| Q3 25 | $87.3M | $162.9M | ||
| Q2 25 | $82.4M | $152.6M | ||
| Q1 25 | $65.0M | $134.3M | ||
| Q4 24 | $69.1M | $200.9M | ||
| Q3 24 | $51.6M | $258.9M | ||
| Q2 24 | $73.8M | $186.2M | ||
| Q1 24 | $137.7M | $155.5M |
净利润ESPRGPRO
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-21.3M | ||
| Q2 25 | $-12.7M | $-16.4M | ||
| Q1 25 | $-40.5M | $-46.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-8.2M | ||
| Q2 24 | $-61.9M | $-47.8M | ||
| Q1 24 | $61.0M | $-339.1M |
毛利率ESPRGPRO
| Q4 25 | — | 31.8% | ||
| Q3 25 | — | 35.1% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 32.1% | ||
| Q4 24 | — | 34.7% | ||
| Q3 24 | — | 35.5% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 34.1% |
营业利润率ESPRGPRO
| Q4 25 | 50.6% | -4.1% | ||
| Q3 25 | -11.4% | -9.8% | ||
| Q2 25 | 8.6% | -9.2% | ||
| Q1 25 | -34.0% | -33.7% | ||
| Q4 24 | -6.4% | -19.5% | ||
| Q3 24 | -31.0% | -3.1% | ||
| Q2 24 | 3.5% | -25.0% | ||
| Q1 24 | 52.5% | -26.6% |
净利率ESPRGPRO
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -13.0% | ||
| Q2 25 | -15.4% | -10.8% | ||
| Q1 25 | -62.2% | -34.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -3.2% | ||
| Q2 24 | -83.9% | -25.7% | ||
| Q1 24 | 44.3% | -218.1% |
每股收益（稀释后）ESPRGPRO
| Q4 25 | $0.32 | $-0.06 | ||
| Q3 25 | $-0.16 | $-0.13 | ||
| Q2 25 | $-0.06 | $-0.10 | ||
| Q1 25 | $-0.21 | $-0.30 | ||
| Q4 24 | $-0.14 | $-0.22 | ||
| Q3 24 | $-0.15 | $-0.05 | ||
| Q2 24 | $-0.33 | $-0.31 | ||
| Q1 24 | $0.34 | $-2.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $49.7M |
| 总债务越低越好 | — | $44.3M |
| 股东权益账面价值 | $-302.0M | $76.5M |
| 总资产 | $465.9M | $428.0M |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资ESPRGPRO
| Q4 25 | $167.9M | $49.7M | ||
| Q3 25 | $92.4M | $152.8M | ||
| Q2 25 | $86.1M | $58.6M | ||
| Q1 25 | $114.6M | $69.6M | ||
| Q4 24 | $144.8M | $102.8M | ||
| Q3 24 | $144.7M | $130.2M | ||
| Q2 24 | $189.3M | $133.0M | ||
| Q1 24 | $226.6M | $133.7M |
总债务ESPRGPRO
| Q4 25 | — | $44.3M | ||
| Q3 25 | — | $43.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $93.1M | ||
| Q2 24 | — | $92.9M | ||
| Q1 24 | — | $92.7M |
股东权益ESPRGPRO
| Q4 25 | $-302.0M | $76.5M | ||
| Q3 25 | $-451.4M | $80.5M | ||
| Q2 25 | $-433.5M | $97.9M | ||
| Q1 25 | $-426.2M | $110.0M | ||
| Q4 24 | $-388.7M | $151.7M | ||
| Q3 24 | $-370.2M | $183.9M | ||
| Q2 24 | $-344.2M | $184.7M | ||
| Q1 24 | $-294.3M | $224.9M |
总资产ESPRGPRO
| Q4 25 | $465.9M | $428.0M | ||
| Q3 25 | $364.0M | $538.6M | ||
| Q2 25 | $347.1M | $439.0M | ||
| Q1 25 | $324.0M | $462.5M | ||
| Q4 24 | $343.8M | $543.7M | ||
| Q3 24 | $314.1M | $661.6M | ||
| Q2 24 | $352.3M | $556.8M | ||
| Q1 24 | $373.1M | $575.8M |
负债/权益比ESPRGPRO
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.55× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.51× | ||
| Q2 24 | — | 0.50× | ||
| Q1 24 | — | 0.41× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $15.6M |
| 自由现金流经营现金流 - 资本支出 | — | $15.0M |
| 自由现金流率自由现金流/营收 | — | 7.4% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-24.0M |
8季度趋势，按日历期对齐
经营现金流ESPRGPRO
| Q4 25 | $45.2M | $15.6M | ||
| Q3 25 | $-4.3M | $12.2M | ||
| Q2 25 | $-31.4M | $8.8M | ||
| Q1 25 | $-22.6M | $-57.2M | ||
| Q4 24 | $-35.0M | $-25.1M | ||
| Q3 24 | $-35.3M | $-2.2M | ||
| Q2 24 | $-7.2M | $605.0K | ||
| Q1 24 | $53.8M | $-98.4M |
自由现金流ESPRGPRO
| Q4 25 | — | $15.0M | ||
| Q3 25 | — | $11.2M | ||
| Q2 25 | — | $8.3M | ||
| Q1 25 | — | $-58.5M | ||
| Q4 24 | — | $-25.5M | ||
| Q3 24 | $-35.5M | $-4.2M | ||
| Q2 24 | $-7.3M | $-111.0K | ||
| Q1 24 | $53.8M | $-99.4M |
自由现金流率ESPRGPRO
| Q4 25 | — | 7.4% | ||
| Q3 25 | — | 6.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -43.5% | ||
| Q4 24 | — | -12.7% | ||
| Q3 24 | -68.7% | -1.6% | ||
| Q2 24 | -9.9% | -0.1% | ||
| Q1 24 | 39.0% | -63.9% |
资本支出强度ESPRGPRO
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.6% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ESPRGPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
GPRO
| Subscription And Services | $106.3M | 53% |
| Other | $95.4M | 47% |
